FBLAD-U95 set | FBLAD-Exon set | |
---|---|---|
Patients | n = 75 | n = 125 |
Sex | ||
Male, n (%) | 61 (81.3) | 100 (80.0) |
Female, n (%) | 14 (18.7) | 25 (20.0) |
Mean age at surgery, years ± SD | 62.8 ± 13.8 | 69.7 ± 15.2 |
Mean follow-up, months ± SD | 40.1 ± 40.0 | 33.6 ± 29.7 |
Bladder tumors | ||
Clinical presentation | ||
Incident tumors, n (%) | 58 (77.3) | 107 (85.6) |
Recurrent tumors, n (%) | 17 (22.7) | 18 (14.4) |
TNM 2009 Stage | ||
Ta, n (%) | 24 (32.0) | 24 (19.2) |
T1, n (%) | 12 (16.0) | 32 (25.6) |
T ≥ 2, n (%) | 39 (52.0) | 69 (55.2) |
WHO 1973 Grade | ||
G1, n (%) | 11 (14.7) | 5 (4.0) |
G2, n (%) | 23 (30.7) | 26 (20.8) |
G3, n (%) | 41 (54.7) | 94 (75.2) |